文献速递乳腺癌放疗放疗物理与技术

腋窝-侧胸壁交界区剂量学参数预测乳腺癌相关淋巴水肿风险

Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema.
PubMed 文献 · Radiother Oncol · 2026-08-13

本研究纳入722例2018至2020年接受手术及辅助放疗的乳腺癌患者,回顾性勾画腋窝-侧胸壁交界区(ALTJ),分析其剂量体积参数与乳腺癌相关淋巴水肿(BCRL)的关系。多因素Cox回归显示ALTJ V35Gy>50%与BCRL风险升高相关(p=0.003,HR 3.07),而二元区域淋巴结照射(RNI)状态无显著关联。将ALTJ剂量参数纳入预测模型可提升预后评估的统计学拟合优度。

要点

  • ALTJ V35Gy>50%与BCRL风险升高相关(HR 3.07,p=0.003)。
  • 二元RNI状态与BCRL风险无显著关联(p=0.363)。
  • 含ALTJ参数的模型统计拟合优于含RNI的模型。

核心结论

  • ALTJ作为感兴趣器官,其剂量学参数可预测乳腺癌放疗后BCRL风险。
  • 将ALTJ剂量参数纳入预测模型可提升预后准确性,弥补RNI野定义不统一的局限。

研究设计与样本

  • 回顾性研究,纳入2018至2020年接受手术及辅助放疗的乳腺癌患者722例,中位随访30个月。
  • BCRL定义为放疗后新发上臂淋巴水肿且国际淋巴学会分期≥2级。
  • 回顾性勾画ALTJ,采用多因素Cox回归和随机生存森林模型分析临床因素与ALTJ剂量参数。
  • 通过Harrell C指数和24个月landmark分析评估模型性能。

主要发现

  • 283例(39.2%)接受腋窝淋巴结清扫(ALND)。
  • 多因素Cox回归中,除ALND外,ALTJ V35Gy>50%与BCRL风险升高相关(p=0.003,HR 3.07)。
  • 二元RNI状态与BCRL风险无显著关联(p=0.363)。
  • 含ALTJ V35Gy的模型B统计拟合优于含RNI的模型A,C指数数值更高(0.753 vs 0.749),但差异无统计学意义。

关键数值与推荐

  • BCRL定义:放疗后新发上臂淋巴水肿,国际淋巴学会分期≥2级。
  • ALTJ V35Gy>50%为BCRL风险升高的相关剂量学阈值(p=0.003,HR 3.07)。

临床怎么用

  • 乳腺癌辅助放疗计划评估时可关注ALTJ的V35Gy,若超过50%提示BCRL风险升高。
  • 以ALTJ剂量参数辅助或替代二元RNI状态进行BCRL风险分层可能更准确。

局限性

  • ALTJ为回顾性勾画,存在勾画变异可能。
  • 模型B较模型A的C指数提升无统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Regional nodal irradiation (RNI) is associated with breast cancer-related lymphedema (BCRL), yet varying definition of extensive RNI among radiation oncologists leads to the inconsistencies in risk assessment. Recently, the axillary-lateral thoracic junction (ALTJ) has been proposed as a potential organ-of-interest, but its role remains controversial. This study investigates the predictive role of ALTJ dose-volumetric parameters in BCRL development. METHODS AND MATERIALS: We identified patients with breast cancer who underwent surgery and adjuvant radiotherapy (2018 - 2020). BCRL was defined as newly developed upper arm lymphedema after radiotherapy, with International Society of Lymphology stage ≥ 2. Following retrospective ALTJ contouring, multivariable Cox regression and Random Survival Forest models were developed using clinical factors and ALTJ dosimetric parameters. Model performance was evaluated via Harrell's C-index and 24-month landmark analysis. RESULTS: We investigated 722 patients with a median follow-up of 30 months. 283 (39.2%) underwent axillary lymph node dissection (ALND). In multivariate Cox regression, along with ALND, ALTJ V35Gy > 50% was associated with an increased risk BCRL (p = 0.003, HR 3.07), whereas binary RNI status wasn't (p = 0.363). When comparing multivariable prognostic frameworks, Model B (incorporating ALTJ V35Gy) demonstrated a more favorable statistical fit than Model A (incorporating RNI). While Model B yielded a numerically higher C-index (0.753 vs. 0.749), this gain was not statistically significant. CONCLUSIONS: This study highlights the significance of the ALTJ as an organ-of-interest in breast cancer patients who underwent radiotherapy. Incorporating ALTJ dosimetric parameters into predictive models enhances prognostic accuracy, addressing the limitations of variable RNI field definitions.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Hong SW, Kim EK, Shin HC, et al. Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema. Radiother Oncol. 2026. PMID: 42595256. doi:10.1016/j.radonc.2026.111725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。